| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 80/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| product name | Ambroxol Hydrochloride |
| CAS NO. | 23828-92-4 |
| Specification | 99% |
| Appearance | white powder |
| Package | 1KG/Bag,5kg/bag,25kg/drum |
| MOQ | 1KG |
Ambroxol hydrochloride is an organic compound with the chemical formula C13H19Br2ClN2O. It is a white to light yellow crystalline powder. It is mainly used as an expectorant. It can promote the removal of viscous secretions in the respiratory tract and reduce the retention of mucus, thus significantly It promotes expectoration and is suitable for acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor expectoration function.
Appearance: white or light yellow crystalline powder
Solubility: slightly soluble in water,
Content: 99.0~101.0%
Melting point: 235~240ºC PH: 4.5~6.0 Heavy metals: ≤20ppm
Loss on drying: ≤0.5% Sulfate ash: ≤0.1%
Single impurity: ≤0.1% Total impurity: ≤0.3%
Used in scientific research and chemical reagents
Packaging: 25KG/cardboard barrel, can be packaged separately according to customer requirements
Storage: light-shielded, dry and sealed storage, valid for 3 years
| ANALYSIS ITEMS | SPECIFICATION | Results |
| Appearance | white powder | Complies |
| Assay | ≥ 99.0% | 99.20% |
| Lead | ≤3ppm | Complies |
| Arsenic | ≤1ppm | Complies |
| Heavy metals(Pb) | ≤10ppm | Complies |
| Hydrazine | ≤2ppm | Complies |
| Total plate count | ≤1000cfu/G | Complies |
| Total yeast&mold | ≤100cfu/G | Complies |
| Loss on drying | ≤1.0% | Complies |
| Residue on ignition | ≤0.10% | Complies |
Effects:
Used for the expectorant treatment of acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and tracheal asthma. Injection can be used to prevent postoperative pulmonary complications and treat respiratory distress syndrome in premature infants and newborns.
Dosage and Administration:
For injection, for adults and children over 12 years old: 2 to 3 times a day, 15 mg each time, slow intravenous infusion; in severe cases, the dose can be increased to 30 mg each time.
){kind=link}